drugset / Trial / NCT06511011

Chinese Medicine in Treating Insomnia

NCT06511011 ↗

Phase 2 Not yet recruiting 76 enrolled Chinese University of Hong Kong
RandomizedParallel-groupTriple-blindTreatment

Summary

This is a randomized, double-blinded, placebo-controlled clinical trial. Eligible participants will randomized into either treatment group (CM granules) or placebo group (placebo granules) for 6 weeks, followed by a post-treatment visit at week 9. The primary outcome is the change in Pittsburgh Sleep Quality Index (PSQI) at week 6.

Timeline

Start
2024-09
Primary completion
2026-05
Completion
2026-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Modified Suan ZaoRen Tang-TianWang BuXin Dan Traditional medicine (herbal / TCM) — —

Indications